Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Factor Viia

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Factor Viia:

Pubmed Logo
[Bleeding complications due to anticoagulatoric therapy.]
Anticoagulation is a standard treatment in patients with thrombosis and...
20th November, 2009
Haemostas, Praxis und Labor zur Diagnostik und Therapie von Internist (Berl). 2009 Nov 20.
DOI Direct Link
The "off-label" role of recombinant factor VIIa in surgery: is the problem deficient evidence or defective concept?
BACKGROUND: Fulminant hepatic failure (FHF) is associated with profound...
11th November, 2009
Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA. J Am Coll Surg. 2009 Nov;209(5):659-67. Epub 2009 Sep 19.
DOI Direct Link
Amniotic fluid embolism: an evidence-based review.
We reviewed the best evidence on amniotic fluid embolism (AFE). The...
3rd November, 2009
Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Am J Obstet Gynecol. 2009 Nov;201(5):445.e1-13.
DOI Direct Link
Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes.
Background and Objectives Recombinant activated factor VIIa (rFVIIa) is...
3rd November, 2009
Department of Epidemiology and Preventive Medicine, Monash University, Vox Sang. 2009 Oct 29.
DOI Direct Link
Alternatively spliced tissue factor induces angiogenesis through integrin ligation.
The initiator of coagulation, full-length tissue factor (flTF), in complex...
31st October, 2009
The Einthoven Laboratory for Experimental Vascular Medicine and Department Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19497-19502. Epub 2009 Oct
DOI Direct Link

View more research publications.

Press Releases About Factor Viia:

BioPortfolio Logo
Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 20th November, 2009 Reportlinker
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Blood Pressure Monitoring & Measurement Instruments - A World Market
Highest Rates of Obesity, Diabetes in the South, Appalachia, and Some Tribal Lands 19th November, 2009 Centers for Disease Control and Prevention
Estimates of Obesity Now Available for all U.S. Counties Wide sections of the Southeast, Appalachia, and some tribal lands in the West and Northern Plains have the nation's highest rates of
/C O R R E C T I O N -- Teva UK Ltd/ 18th November, 2009
LEEDS, England, November 18 /PRNewswire/ -- In the news release, "Teva Launches TevaGrastim(R) (filgrastim)" issued on 18 Nov 2009 07:00 GMT, by Teva UK Ltd over PR Newswire, due to an
Reportlinker Adds Anticoagulants - A Global Market Review 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Anticoagulants - A Global Market Review http://www.reportlinker.com
Teva Launches TevaGrastim(R) (filgrastim) 18th November, 2009
LEEDS, England, November 18 /PRNewswire/ -- Teva UK Limited has signalled its commitment to developing biosimilar medicines by entering the G-CSF* therapy area. The launch of its proprietary version

BioNews Results for Factor Viia:

RSS Logo
BioPortfolio Logo
GTC Biotherapeutics Receives Extension to Regain Compliance with NASDAQ Listing Standards
SmartBrief:  Nov 20 2009 6:49AM Matching: factor viia
GTC Biotherapeutics Receives Extension to Regain Compliance with NASDAQ Listing Standards
Yahoo! Canada:  Nov 19 2009 2:36PM Matching: factor viia
Maxygen to buy back 6.6M shares
Biz Journals:  Nov 13 2009 5:21PM Matching: factor viia
GTC slashes workforce as cash reserves dwindle
FierceBiotech:  Nov 9 2009 7:52PM Matching: factor viia
GTC Biotherapeutics announces financial results for third quarter 2009
News-Medical.Net:  Nov 7 2009 4:56AM Matching: factor viia
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Factor Viia Patents:

USPTO Logo
US Patent No.Title
7553940 Long-acting EPO polypeptides and derivatives thereof and methods thereof
7579000 Tissue factor targeted antibodies as anticoagulants
7579346 Carboxamides
7579375 Branched carboxylic acid compound and use thereof
7582284 Particulate materials

View more patents.

Companies working in the area of Factor Viia from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Nuvelo

Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute...
www.nuvelo.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Factor Viia scientists - we have details of around 239 individuals working on Factor Viia .


This page has been viewed 340 times
Recent Search Terms used to find this page: Factor VIIa LFB 2009 | synthesis and characterization of recombinant factor viia conjugated | Factor VIIa patent number | Symposium on Hemostasis with Special Focus on Factor .... | Symposium on Hemostasis with Special Focus on Factor .... | factor 7a wiki | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Factor Viia across BioPortfolio, or for Factor Viia Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.